The role of glutathione in dopaminergic neuronal survival

Journal of Neurochemistry

Volumn 69, Issue 5, 1997, Pages 1850-1858

  Nakamura, Ken ^a   Wang, Wenyi ^a   Kang, Un Jung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

1 Methyl 4 phenylpyridinium; Free radicals; L Buthionine (S,R) sulfoximine; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BUTHIONINE SULFOXIMINE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0030779127     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69051850.x     Document Type: Article

References (37)

1. Akerboom T. P. M., Bilzer M., and Sies H. (1982) The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J. Biol. Chem. 257, 4248-4252.
2. Andersen J. K., Mo J. Q., Hom D. G., Lee F. Y., Harnish P., Hamill R. W., and McNeill T. H. (1996) Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J. Neurochem. 67, 2164-2171.
3. Bhave S. V., Johannessen J. N., Lash L. H., Wakade T. D., and Wakade A. R. (1996) Age-dependent sensitivity of cultured peripheral sympathetic neurons to 1-methyl-4-phenylpyridinium: role of glutathione. J. Neurochem. 67, 557-565.
4. Chan P. (1996) Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129.
5. Choi H. K., Won L. A., Kontur P. J., Hammond D. N., Fox A. P., Wainer B. H., Hoffman P. C., and Heller A. (1991) Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552, 67-76.
6. Cleeter M. W. J., Cooper J. M., and Shapira A. H. V. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
7. Darley-Usmar V., Wiseman H., and Halliwell B. (1995) Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 369, 131-135.
8. + -induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport. Brain Res. 715, 1-8.
9. Dexter D. T., Sian J., Rose S., Hindmarsh J. G., Mann V. M., Cooper J. M., Wells F. R., Daniel S. E., Lees A. J., Schapira A. H. V., Jenner P., and Marsden C. D. (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35, 38-44.
10. Eklow L., Moldeus P., and Orrenius S. (1984) Oxidation of glutathione during hydroperoxide metabolism. A study using isolated hepatocytes and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea. Eur. J. Biochem. 138, 459-463.
11. Grasbon-Frodl E. M., Andersson A., and Brundin P. (1996) Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67, 1653-1660.
12. Han S.-K., Mytilineou C., and Cohen G. (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66, 501-510.
13. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T., and Beal M. F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2, 1017-1021.
14. +) induces NADH-dependent Superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170, 1049-1055.
15. Hirsch E. C. (1992) Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease. Ann. Neurol. 32 (Suppl.), S88-S93.
16. Jain A., Martensson J., Stole E., Auld P., and Meister A. (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA 88, 1913-1917.
17. Kurosawa K., Shibata H., Hayashi N., Sato N., Kamada T., and Tagawa K. (1990) Kinetics of hydroperoxide degradation by NADP-glutathione system in mitochondria. J. Biochem. (Tokyo) 108, 9-16.
18. Langeveld C. H., Schepens E., Jongenelen C. A. M., Stoof J. C., Hjelle O. P., Ottersen O. P., and Drukarch B. (1996) Presence of glutathione immunoreactivity in cultured neurones and astrocytes. Neuroreport 7, 1833-1836.
19. Liu H. and Kehrer J. (1996) The reduction of glutathione disulfide produced by t-butyl hydroperoxide in respiring mitochondria. Free Radic. Biol. Med. 20, 433-442.
20. Marzatico F., Cafe C., Taborelli M., and Benzi G. (1993) Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas. Neurochem. Res. 18, 1101-1106.
21. Mood A. M., Graybill F. A., and Duene C. B. (1974) Introduction to the Theory of Statistics. McGraw-Hill, New York.
22. Olafsdottir K. and Reed D. J. (1988) Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. Biochim. Biophys. Acta 964, 377-382.
23. Philbert M. A., Beiswanger C. M., Waters D. K., Reuhl K. R., and Lowndes H. E. (1991) Cellular and regional distribution of reduced glutathione in nervous system of rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. Toxicol. Appl. Pharmacol. 107, 215-227.
24. Pileblad E., Eriksson P., and Hansson E. (1991) The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J. Neural Transm. Gen. Sect. 86, 43-49.
25. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., and Dawson T. M. (1996) Role of neuronal nitricoxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565-4571.
26. Sancho-Tello M., Valles S., Montoliu C., Renau-Piqueras J., and Guerri C. (1995) Developmental pattern of GFAP and vimentin gene expression in rat brain and in radial glial cultures. Glia 15, 157-166.
27. Sarafian T. A., Vartavarian L., Kane D. J., Bredesen D. E., and Verity M. A. (1994) bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line. Toxicol. Lett. 74, 149-155.
28. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden D. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neural. 36, 348-355.
29. Sies H. and Summer K. (1975) Hydroperoxide-metabolizing systems in rat liver. J. Biochem. (Tokyo) 57, 503-512.
30. Simplicio P.D. and Rossi R. (1994) The time-course of mixed disulfide formation between GSH and proteins in rat blood after oxidative stress with tert-butyl hydroperoxide. Biochim. Biophys. Acta 1199, 245-252.
31. Slivka A., Mytilineou C., and Cohen G. (1987) Histochemical evaluation of glutathione in brain. Brain Res. 409, 275-284.
32. 2 and photochemically induced cataract. Curr. Eye Res. 12, 163-179.
33. Thiffault C., Aumont N., Quirion R., and Poirier J. (1995) Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65, 2725-2733.
34. Tietze F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
35. + toxicity in nigral dopaminergic neurones. Neuroreport 7, 921-923.
36. Yong V., Perry T., and Krisman A. (1986) Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci. Lett. 63, 56-60.
37. Youdim M. B. H., Ben-Shachar D., and Riederer P. (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8, 1-12.